Literature DB >> 30543848

LncRNA-H19 activates CDC42/PAK1 pathway to promote cell proliferation, migration and invasion by targeting miR-15b in hepatocellular carcinoma.

Yong Zhou1, Ren-Gen Fan1, Cheng-Lin Qin1, Jing Jia2, Xu-Dong Wu3, Wen-Zhang Zha4.   

Abstract

BACKGROUND: Hepatocellular carcinoma (HCC) is one of the main causes of cancer-related death. This study aims to explore the role and underlying mechanism of H19 in HCC.
METHODS: qRT-PCR detected miR-15b-5p and H19 expression, as well as the mRNA level of EMT-associated genes. Western blotting detected protein level of EMT-associated genes. Immunohistochemistry (IHC) examined CDC42 in HCC tissues. Dual luciferase reporter assay verified the regulatory mechanism among H19, miR-15b and CDC42. Colony formation, wound healing assay, transwell, flow cytometry measured proliferation, migration, invasion and apoptosis, respectively.
RESULTS: H19 and CDC42 were up-regulated while miR-15b was down-regulated in HCC cells and tissues. miR-15b interacted with H19 and CDC42 3'-UTR. H19 knockdown inhibited proliferation, migration and invasion, and increased apoptosis, which was rescued by miR-15b inhibitor. H19 knockdown suppressed CDC42/PAK1 pathway and EMT progress.
CONCLUSION: H19 knockdown inhibited proliferation, migration and invasion, and promoted apoptosis of HCC cells via targeting miR-15b/CDC42/PAK1 axis.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CDC42/PAK1 pathway; EMT; Hepatocellular carcinoma; lncRNA-H19; miR-15b

Mesh:

Substances:

Year:  2018        PMID: 30543848     DOI: 10.1016/j.ygeno.2018.12.009

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  27 in total

1.  CDC42 Regulates Cell Proliferation and Apoptosis in Bladder Cancer via the IQGAP3-Mediated Ras/ERK Pathway.

Authors:  Gang Li; Yu Wang; Xiao-Bo Guo; Bo Zhao
Journal:  Biochem Genet       Date:  2022-04-12       Impact factor: 1.890

Review 2.  The long and the small collide: LncRNAs and small heterodimer partner (SHP) in liver disease.

Authors:  Jianguo Wu; Laura E Nagy; Li Wang
Journal:  Mol Cell Endocrinol       Date:  2021-03-26       Impact factor: 4.369

Review 3.  Long noncoding RNA H19 - a new player in the pathogenesis of liver diseases.

Authors:  Zhihong Yang; Ting Zhang; Sen Han; Praveen Kusumanchi; Nazmul Huda; Yanchao Jiang; Suthat Liangpunsakul
Journal:  Transl Res       Date:  2020-11-20       Impact factor: 10.171

Review 4.  The Good, the Bad, the Question-H19 in Hepatocellular Carcinoma.

Authors:  Lysann Tietze; Sonja M Kessler
Journal:  Cancers (Basel)       Date:  2020-05-16       Impact factor: 6.639

Review 5.  Genetic And Epigenetic Regulation Of E-Cadherin Signaling In Human Hepatocellular Carcinoma.

Authors:  Xiaoxiao Fan; Shengxi Jin; Yirun Li; Parikshit Asutosh Khadaroo; Yili Dai; Lifeng He; Daizhan Zhou; Hui Lin
Journal:  Cancer Manag Res       Date:  2019-10-16       Impact factor: 3.989

6.  LncRNA H19 promotes keloid formation through targeting the miR-769-5p/EIF3A pathway.

Authors:  Lingang Xu; Nan Sun; Guangshuai Li; Linbo Liu
Journal:  Mol Cell Biochem       Date:  2021-01-03       Impact factor: 3.396

7.  miR-29a-3p inhibits endometrial cancer cell proliferation, migration and invasion by targeting VEGFA/CD C42/PAK1.

Authors:  Aizhi Geng; Lin Luo; Fengyun Ren; Ling Zhang; Haiying Zhou; Xue Gao
Journal:  BMC Cancer       Date:  2021-07-21       Impact factor: 4.430

8.  miR-15b-3p promotes the malignant progression of endometrial cancer cells through targeting KLF2.

Authors:  Ping Wang; Xiqing Zhao; Xiaotang Wu; Guoshuai Tang; Linna Yuan
Journal:  Cell Cycle       Date:  2021-07-05       Impact factor: 5.173

Review 9.  P21-Activated Kinase 1: Emerging biological functions and potential therapeutic targets in Cancer.

Authors:  Dahong Yao; Chenyang Li; Muhammad Shahid Riaz Rajoka; Zhendan He; Jian Huang; Jinhui Wang; Jin Zhang
Journal:  Theranostics       Date:  2020-08-01       Impact factor: 11.556

10.  Integrative analysis of dysregulated lncRNA-associated ceRNA network reveals potential lncRNA biomarkers for human hepatocellular carcinoma.

Authors:  Chengyun Li; Wenwen Zhang; Hanteng Yang; Jilian Xiang; Xinghua Wang; Junling Wang
Journal:  PeerJ       Date:  2020-03-11       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.